Phosphodiesterases and cAMP Pathway in Pituitary Diseases.
AIP (Aryl hydrocarbon receptor interacting protein)
acromegaly
cAMP pathway
gigantism
phosphodiesterases
pituitary
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2019
2019
Historique:
received:
02
10
2018
accepted:
15
02
2019
entrez:
4
4
2019
pubmed:
4
4
2019
medline:
4
4
2019
Statut:
epublish
Résumé
Human phosphodiesterases (PDEs) comprise a complex superfamily of enzymes derived from 24 genes separated into 11 PDE gene families (PDEs 1-11), expressed in different tissues and cells, including heart and brain. The isoforms PDE4, PDE7, and PDE8 are specific for the second messenger cAMP, which is responsible for mediating diverse physiological actions involving different hormones and neurotransmitters. The cAMP pathway plays an important role in the development and function of endocrine tissues while phosphodiesterases are responsible for ensuring the appropriate intensity of the actions of this pathway by hydrolyzing cAMP to its inactive form 5'-AMP. PDE1, PDE2, PDE4, and PDE11A are highly expressed in the pituitary, and overexpression of some PDE4 isoforms have been demonstrated in different pituitary adenoma subtypes. This observed over-expression in pituitary adenomas, although of unknown etiology, has been considered a compensatory response to tumorigenesis. PDE4A4/5 has a unique interaction with the co-chaperone aryl hydrocarbon receptor-interacting protein (AIP), a protein implicated in somatotroph tumorigenesis via germline loss-of-function mutations. Based on the association of low PDE4A4 expression with germline
Identifiants
pubmed: 30941100
doi: 10.3389/fendo.2019.00141
pmc: PMC6433792
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
141Références
J Biol Chem. 2000 Apr 7;275(14):10349-58
pubmed: 10744723
J Biol Chem. 2000 Sep 8;275(36):28063-74
pubmed: 10829034
J Biol Chem. 2000 Nov 17;275(46):36407-14
pubmed: 10961990
Mol Pharmacol. 2001 May;59(5):996-1011
pubmed: 11306681
J Clin Endocrinol Metab. 2001 Aug;86(8):3795-800
pubmed: 11502813
Cell Signal. 2001 Dec;13(12):911-8
pubmed: 11728831
J Biol Chem. 2002 Apr 5;277(14):11795-801
pubmed: 11805120
Cell Signal. 2002 May;14(5):445-52
pubmed: 11882389
Cell Signal. 2002 May;14(5):453-65
pubmed: 11882390
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13260-5
pubmed: 12271124
Biochem J. 2003 Feb 15;370(Pt 1):1-18
pubmed: 12444918
J Biol Chem. 2003 Feb 21;278(8):5493-6
pubmed: 12493749
Endocrinology. 2003 Apr;144(4):1292-300
pubmed: 12639912
J Biol Chem. 2003 Aug 29;278(35):33351-63
pubmed: 12810716
Mol Pharmacol. 2005 Jun;67(6):1920-34
pubmed: 15738310
J Clin Endocrinol Metab. 2005 Dec;90(12):6721-4
pubmed: 16204369
Science. 2006 May 26;312(5777):1228-30
pubmed: 16728643
Br J Cancer. 2007 Jan 29;96(2):352-6
pubmed: 17242703
J Clin Endocrinol Metab. 2007 May;92(5):1891-6
pubmed: 17244780
J Biol Chem. 2007 May 4;282(18):13656-63
pubmed: 17329248
Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4101-5
pubmed: 17360484
Clin Endocrinol (Oxf). 2007 Apr;66(4):499-502
pubmed: 17371465
Annu Rev Biochem. 2007;76:481-511
pubmed: 17376027
Eur J Endocrinol. 2007 Jul;157(1):1-8
pubmed: 17609395
Biochem J. 2008 Apr 15;411(2):361-9
pubmed: 18095939
J Clin Endocrinol Metab. 2008 Jun;93(6):2390-401
pubmed: 18381572
Clin Endocrinol (Oxf). 2008 Oct;69(4):621-7
pubmed: 18410548
Cancer Res. 2008 May 1;68(9):3523-31
pubmed: 18451181
Exp Clin Endocrinol Diabetes. 2008 Nov;116(10):625-8
pubmed: 18484068
J Clin Endocrinol Metab. 2009 Jul;94(7):2571-8
pubmed: 19366855
Eur J Endocrinol. 2009 Nov;161(5):687-94
pubmed: 19671705
Eur J Endocrinol. 2009 Nov;161(5):799-804
pubmed: 19684062
J Neuroendocrinol. 2009 Nov;21(11):869-77
pubmed: 19732293
J Endocrinol Invest. 2009 May;32(5):426-9
pubmed: 19794292
J Endocrinol Invest. 2010 Dec;33(11):800-5
pubmed: 20354355
Hum Mutat. 2010 Aug;31(8):950-60
pubmed: 20506337
Clin Genet. 2010 Nov;78(5):457-63
pubmed: 20507346
Eur J Endocrinol. 2010 Sep;163(3):369-76
pubmed: 20530095
J Clin Endocrinol Metab. 2010 Nov;95(11):E373-83
pubmed: 20685857
J Clin Endocrinol Metab. 2011 Jan;96(1):E208-14
pubmed: 21047926
N Engl J Med. 2011 Jan 6;364(1):43-50
pubmed: 21208107
Clin Transl Sci. 2011 Feb;4(1):55-62
pubmed: 21348957
J Endocrinol. 2011 Aug;210(2):137-55
pubmed: 21454441
Physiol Rev. 2011 Apr;91(2):651-90
pubmed: 21527734
Eur J Endocrinol. 2011 Aug;165(2):177-88
pubmed: 21602319
Eur J Endocrinol. 2011 Oct;165(4):509-15
pubmed: 21753072
J Clin Endocrinol Metab. 2012 Apr;97(4):E663-70
pubmed: 22319033
World J Urol. 2013 Apr;31(2):325-30
pubmed: 22383129
Ann Endocrinol (Paris). 2012 Apr;73(2):73-5
pubmed: 22525824
Pituitary. 2012 Dec;15 Suppl 1:S61-7
pubmed: 22527616
Clinics (Sao Paulo). 2012;67 Suppl 1:3-6
pubmed: 22584698
Am J Physiol Endocrinol Metab. 2012 Sep 15;303(6):E708-19
pubmed: 22811466
Pituitary. 2013 Jun;16(2):238-44
pubmed: 22915287
Eur J Endocrinol. 2012 Dec;167(6):759-68
pubmed: 22992986
Eur J Endocrinol. 2012 Dec 10;168(1):9-13
pubmed: 23038625
PLoS One. 2012;7(12):e53339
pubmed: 23300914
Eur J Endocrinol. 2013 Mar 15;168(4):533-41
pubmed: 23321498
Endocr Rev. 2013 Apr;34(2):239-77
pubmed: 23371967
J Clin Endocrinol Metab. 2013 Jul;98(7):2800-10
pubmed: 23633209
Endocr Relat Cancer. 2013 Jun 27;20(4):495-505
pubmed: 23702468
Pituitary. 2014 Jun;17(3):220-6
pubmed: 23743763
J Mol Endocrinol. 2013 Dec 19;52(1):R67-77
pubmed: 24049068
Eur J Endocrinol. 2013 Oct 23;169(6):867-84
pubmed: 24050928
J Clin Endocrinol Metab. 2014 Apr;99(4):1122-31
pubmed: 24423289
Oncogene. 2015 Feb 26;34(9):1174-84
pubmed: 24662816
Nat Rev Drug Discov. 2014 Apr;13(4):290-314
pubmed: 24687066
Dermatol Online J. 2014 May 16;20(5):22608
pubmed: 24852768
Biochemistry. 2014 Aug 5;53(30):4938-45
pubmed: 25050706
Endocrinol Diabetes Metab Case Rep. 2014;2014:140048
pubmed: 25136448
Endocrinol Diabetes Metab Case Rep. 2015;2015:140105
pubmed: 25614825
PLoS One. 2015 Feb 06;10(2):e0117107
pubmed: 25658813
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Pituitary. 2015 Dec;18(6):831-7
pubmed: 26021842
J Clin Endocrinol Metab. 2015 Sep;100(9):E1242-54
pubmed: 26186299
J Clin Endocrinol Metab. 2016 Aug;101(8):3144-54
pubmed: 27253664
Endocr Relat Cancer. 2016 May;23(5):419-31
pubmed: 27267386
Hum Mutat. 2017 Jan;38(1):78-85
pubmed: 27650164
Eur J Endocrinol. 2017 May;176(5):635-644
pubmed: 28220018
Horm Cancer. 2017 Jun;8(3):174-184
pubmed: 28255869
Horm Metab Res. 2017 Apr;49(4):286-295
pubmed: 28427099
Eur J Endocrinol. 2017 Sep;177(3):257-266
pubmed: 28634279
Mol Cell Endocrinol. 2018 Mar 5;463:72-86
pubmed: 28822849
Adv Neurobiol. 2017;17:63-102
pubmed: 28956330
J Med Genet. 2018 Apr;55(4):254-260
pubmed: 29440248
Endocrinol Diabetes Metab Case Rep. 2018 Feb 09;2018:null
pubmed: 29472986
J Med Genet. 2018 Aug;55(8):522-529
pubmed: 29632148
Hum Mol Genet. 2018 May 2;:null
pubmed: 29726992
Mol Cell Endocrinol. 2018 Nov 15;476:103-109
pubmed: 29729370
Pediatr Pulmonol. 2018 Sep;53(9):1318-1325
pubmed: 29905405
Gene. 1994 Nov 18;149(2):237-44
pubmed: 7958996
Mol Cell Biol. 1993 Oct;13(10):6558-71
pubmed: 8413254
J Biol Chem. 1996 Jan 12;271(2):1065-71
pubmed: 8557632
Adv Pharmacol. 1998;44:225-342
pubmed: 9547887
J Clin Endocrinol Metab. 1999 Jan;84(1):249-56
pubmed: 9920092